In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases.

Antimicrob Agents Chemother

Serviço de Micologia Médica, Instituto de Pesquisa Clínica Evandro Chagas, FIOCRUZ, Rio de Janeiro, Brazil.

Published: September 2005

We have determined the antifungal susceptibilities of 34 clinical isolates of the dimorphic fungus Sporothrix schenckii to 11 drugs using a microdilution method. In general, the type of growth phase (mycelial or yeast) and the temperature of incubation (30 or 35 degrees C) exerted a significant influence on the MICs.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1195444PMC
http://dx.doi.org/10.1128/AAC.49.9.3952-3954.2005DOI Listing

Publication Analysis

Top Keywords

antifungal susceptibilities
8
sporothrix schenckii
8
vitro antifungal
4
susceptibilities sporothrix
4
schenckii growth
4
growth phases
4
phases determined
4
determined antifungal
4
susceptibilities clinical
4
clinical isolates
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!